|
P001
|
Antimicrobial drug penetration in human abdominal abscesses
Poster flash presentation & Poster
SSI
A. Cancela Costa
Speaker
Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)A. Kritikos CHUV - University HospitalE. Glampedakis CHUV - University HospitalF. Grass CHUV - University HospitalE. Uldry CHUV - University HospitalC. Delabays CHUV - University HospitalF. Schaller CHUV - University HospitalJ. Pagani CHUV - University HospitalB. Guerry CHUV - University HospitalL. Decosterd CHUV - University HospitalF. Lamoth CHUV - University Hospital
|
|
P002
|
Evaluation of the 2023 Duke-ISCVID criteria for infective endocarditis in a multicenter cohort of patients with suspected infective endocarditis
Poster flash presentation & Poster
SSI
M. Papadimitriou-Olivgeris
Speaker
Lausanne University Hospital and University of LausanneP. Monney Lausanne University Hospital and University of LausanneM. Frank University Hospital Zurich and University of ZurichG. Tzimas Lausanne University Hospital and University of LausanneP. Tozzi Lausanne University Hospital and University of LausanneM. Kirsch Lausanne University Hospital and University of LausanneM. Van Hemelrijck University Hospital Zurich and University of ZurichR. Bauernschmitt University Hospital Zurich and University of ZurichB. Guery Lausanne University Hospital and University of LausanneB. Hasse University Hospital Zurich and University of Zurich
|
|
P003
|
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
Poster flash presentation & Poster
SSI
I. Abela
Speaker
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandC. Pasin Institute of Medical Virology, University of Zurich, SwitzerlandM. Schwarzmüller Institute of Medical Virology, University of Zurich, SwitzerlandA. Ulyte Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland T. Radtke Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland S. Haile Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland P. Ammann Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland S. Epp Institute of Medical Virology, University of Zurich, SwitzerlandC. Berger University Children Hospital Zurich, SwitzerlandJ. Böni Institute of Medical Virology, University of Zurich, SwitzerlandA. Manrique Institute of Medical Virology, University of Zurich, SwitzerlandA. Audigé Institute of Medical Virology, University of Zurich, SwitzerlandH. Michael Institute of Medical Virology, University of Zurich, SwitzerlandP. Schreiber Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandT. Scheier Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandJ. Fehr Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland J. Weber Institute of Medical Virology, University of Zurich, SwitzerlandP. Rusert Institute of Medical Virology, University of Zurich, SwitzerlandH. Günthard Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandR. Kouyos Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandM. Puhan Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland S. Kriemler Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland A. Trkola Institute of Medical Virology, University of Zurich, Switzerland
|
|
P004
|
|
|
P005
|
|
|
P006
|
|
|
P007
|
|
|
P008
|
|
|
P009
|
|
|
P010
|
An improved ex vivo rat model of Tick-borne encephalitis
Poster flash presentation & Poster
SSI
S. Leoni
Speaker
Institute for Infectious Diseases, University of BernD. Grandgirard Institute for Infectious Diseases, University of BernS. Leib Institute for Infectious Diseases, University of Bern
|
|
P011
|
|
|
P012
|
Evolution of symptoms compatible with post-COVID condition after Wild-type infection and influence of Omicron BA.1 reinfection and SARS-CoV-2 vaccinations
Poster flash presentation & Poster
SSI
C. Strahm
Speaker
Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyC. Kahlert Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyS. Guesewell Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyU. Besold Geriatric Clinic St. GallenE. Betschon Clienia Littenheid AG, Private Clinic for Psychiatry and PsychotherapyA. Brucher Psychiatry Services of the Canton of St. Gallen (South)A. Cusini Cantonal Hospital of Grisons, Division of Infectious DiseasesS. Goppel Psychiatry Services of the Canton of St. Gallen (North)A. McGeer Sinai Health System,C. Moeller Center for Neurological RehabilitationM. Ortner Rheintal Werdenberg Sarganserland Hospital GroupL. Risch Labormedizinisches Zentrum Dr Risch Ostschweiz AGM. Ruetti Fuerstenland Toggenburg Hospital GroupM. Schlegel Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyR. Stocker Hirslanden ClinicP. Vernazza Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyD. Vuichard-Gysin Thurgau Hospital Group, Division of Infectious Diseases and Hospital EpidemiologyB. Wiggli Cantonal Hospital Baden, Division of Infectious Diseases and Hospital EpidemiologyS. Kuster Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyP. Kohler Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology
|
|
P013
|
|
|
P014
|
Rectal carriage of multidrug-resistant organisms in healthcare personnel – a multicentre cross-sectional study
Poster flash presentation & Poster
SSHH
T. Badinski Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenS. Seiffert Division of Human Microbiology, Centre for Laboratory Medicine, St. GallenF. Grässli Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenB. Babouee Flury Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenU. Besold Geriatric Clinic St. GallenE. Betschon Clienia Littenheid AGA. Brucher Psychiatry Services of the Canton of St. GallenA. Cusini Division of Infectious Diseases, Cantonal Hospital of Grisons, ChurA. Egli Institute of Medical Microbiology, University of ZurichS. Goppel Psychiatry Services of the Canton of St. GallenJ. Keller Hirslanden Clinic ZurichM. von Kietzell Hirslanden Clinic StephanshornJ. Möller Center for Neurological Rehabilitation ZihlschlachtO. Nolte Division of Human Microbiology, Centre for Laboratory Medicine, St. GallenM. Ortner Sarganserland Rheintal Werdenberg Hospital Group, SwitzerlandM. Ruetti Fuerstenland Toggenburg Hospital Group, Wil, SwitzerlandM. Schlegel Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenH. Seth-Smith Institute of Medical Microbiology, University of ZurichR. Stephan Section of Veterinary Bacteriology, Institute for Food Safety and Hygiene, University of ZurichR. Stocker Hirslanden Clinic ZurichD. Vuichard-Gysin Thurgau Hospital Group, Division of Infectious Diseases and Hospital Epidemiology, MuensterlingenB. Willi Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, ZurichS. Kuster Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenC. Kahlert Children's Hospital of Eastern Switzerland, Department of Infectious Diseases and Hospital Epidemiology, St. GallenP. Kohler
Speaker
Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen
|
|
P015
|
The Challenges of Controlling Scabies in Asylum Centers: Lessons from the Canton of St. Gallen and Call for a Standardized National Approach
Poster flash presentation & Poster
SSHH
M. Seneghini
Speaker
Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandA. Cozzio Department of Dermatology, Venereology and Allergology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.H. Gammeter Cantonal medical service, Canton St. Gallen, SwitzerlandS. Heim Trägerverein Integrationsprojekte St. GallenM. Koller State secretariat for Migration (SEM), BernS. Kuster Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandM. Schlegel Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandP. Schwarz Federal asylum center, Altstätten R. Tamò Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandD. Flury Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
|
|
P016
|
|
|
P017
|
Effective infection prevention and control measures in long-term care facilities in non-outbreak and outbreak settings – a systematic literature review
Poster flash presentation & Poster
SSHH
N. Bloch
Speaker
Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandJ. Männer Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandC. Gardiol Federal Office of Public Health, Bern, SwitzerlandP. Kohler Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandJ. Kuhn Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandT. Münzer Geriatrische Klinik St. Gallen, St Gallen, Cantonal Hospital St Gallen, SwitzerlandM. Schlegel Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandS. Kuster Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandD. Flury Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland
|
|
P018
|
Screening and whole genome sequencing during an outbreak of Serratia marcescens in a neonatal and pediatric ICU
Poster flash presentation & Poster
SSHH
A. Summerauer
Speaker
Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, SwitzerlandS. Egger Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, SwitzerlandS. Baars Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, SwitzerlandB. Ivàdy Department of Intensive Care and Neonatology, University Children's Hospital Zurich, SwitzerlandL. Schlapbach Department of Intensive Care and Neonatology, University Children's Hospital Zurich, SwitzerlandR. Stephan Institute for Food Safety and Hygiene University of Zurich, SwitzerlandC. Berger Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Switzerland
|
|
P019
|
|
|
P020
|
|
|
P021
|
Experiences and Perspectives of Travelers and Health Professionals on Integrated Sexual Health Pre-travel Counseling in the Era of PrEP
Poster flash presentation & Poster
SSTTM
N. Stürmer
Speaker
University of Zurich UZHM. Rasi University of Zurich UZHC. Moser University of Zurich UZHF. Sommer Stalder University of Zurich UZHJ. Giovanoli Evack University of Zurich UZHK. Siebenhuener University of Zurich UZHA. Anagnostopoulos University of Zurich UZHR. Novillo University of Zurich UZHA. van't Westeinde University of Zurich UZHO. Vrankovic Checkpoint ZurichB. Hampel University of Zurich UZH AND Checkpoint ZurichJ. Fehr University of Zurich UZHD. Nicca University of Zurich UZH
|
|
P022
|
|
|
P023
|
|
|
P024
|
|
|
P025
|
Prevalence of infective endocarditis among patients with bacteraemia due to different streptococcal species
Poster (only)
SSI
N. Fourré
Speaker
Lausanne University Hospital and University of LausanneV. Zimmermann Lausanne University Hospital and University of LausanneP. Monney Lausanne University Hospital and University of LausanneL. Senn Lausanne University Hospital and University of LausanneB. Guery Lausanne University Hospital and University of LausanneM. Papadimitriou-Olivgeris Lausanne University Hospital and University of Lausanne
|
|
P026
|
Dynamic of pediatric invasive bacterial infections in Switzerland before, during and after application of non-pharmaceutical interventions against COVID-19
Poster (only)
SSI
M. Jaboyedoff
Speaker
Pediatric Infectious Diseases and Vaccinology Unit, Service of Pediatrics, Department Women-Mother-Child, Lausanne University Hospital and University of Lausanne, LausanneA. Niederer-Loher Division of Infectious Diseases and Hospital Epidemiology, Children's Hospital of Eastern Switzerland, St GallenC. Kahlert Division of Infectious Diseases and Hospital Epidemiology, Children's Hospital of Eastern Switzerland, St GallenP. Crisinel Pediatric Infectious Diseases and Vaccinology Unit, Service of Pediatrics, Department Women-Mother-Child, Lausanne University Hospital and University of Lausanne, LausanneF. Angoulvant Service of Pediatrics, Department Women-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne
|
|
P027
|
|
|
P028
|
|
|
P029
|
|
|
P030
|
|
|
P031
|
|
|
P032
|
|
|
P034
|
Outcomes after switching from 144 weeks of blinded DTG/ABC/3TC or DTG+F/TAF to 96 weeks of open-label B/F/TAF
Poster (only)
SSI
C. Orkin Queen Mary University of LondonA. Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, RomeJ. Rockstroh Bonn University HospitalS. Moreno Guillén Hospital Universitario Ramón y CajalC. Martorell The Research InstituteJ. Molina Université de ParisA. Lazzarin San Raffaele HospitalF. Maggiolo Ospedale San GiovanniY. Yazdanpanah Bichat Hospital, Paris Descartes UniversityK. Andreatta Gilead Sciences, Inc.H. Huang Gilead Sciences, Inc.J. Hindman Gilead Sciences, Inc.H. Martin Gilead Sciences, Inc.T. Grabinger
Speaker
Gilead Sciences Switzerland SàrlJ. Baeten Gilead Sciences, Inc.A. Pozniak Chelsea and Westminster Hospital
|
|
P035
|
Infectious Disease Events after kidney re-transplantation compared to first kidney transplantation: data from the STCS
Poster (only)
SSI
K. Kusejko
Speaker
UniversitätsSpital ZürichD. Neofytos University Hospital of GenevaH. Hirsch University of BaselP. Meylan University of LausanneK. Boggian KSSGC. Hirzel Inselspital - Universitätsspital BernC. Garzoni Clinica Luganese MoncuccoD. Sidler Inselspital - Universitätsspital BernA. Schnyder KSSGS. Schaub University Hospital BaselD. Golshayan Lausanne University HospitalF. Haidar University Hospital of GenevaM. Bonani University Hospital Zurich, Zurich, SwitzerlandR. Kouyos University Hospital ZurichN. Müller University Hospital ZurichP. Schreiber University Hospital Zurich
|
|
P036
|
Incidence and resistance rate of Pseudomonas aeruginosa bloodstream infections in Switzerland: a nationwide surveillance study (2008 – 2021)
Poster (only)
SSI
A. Burri
Speaker
Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernL. Renggli Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernS. Ehrhard Emergency Department, Inselspital, University Hospital Bern and University of BernM. Gasser Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernA. Kronenberg Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern
|
|
P037
|
Frequent HBsAg clearance during tenofovir therapy in HIV/HBV-coinfection
Poster (only)
SSI
C. Béguelin
Speaker
Inselspital, Bern University HospitalE. Hofmann Inselspital, Bern University HospitalB. Surial Inselspital, Bern University HospitalA. Munting Lausanne University Hospital and University of LausanneH. Günthard University Hospital ZurichM. Stöckle University Hospital BaselE. Bernasconi Regional hospital of LuganoP. Schmid Cantonal Hospital of St. GallenA. Calmy Geneva University HospitalF. Suter-Riniker Institute for Infectious Diseases, University of Bern, SwitzerlandA. Rauch Inselspital, Bern University HospitalG. Wandeler Inselspital, Bern University Hospital
|
|
P038
|
|
|
P039
|
Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults With HIV-1: Week 240 Results of the Phase 3 BRIGHTE Study
Poster (only)
SSI
J. Aberg Icahn School of Medicine at Mount Sinai, New York, NY, USAB. Shepherd GSK, Brentford, UKM. Wang GSK, Collegeville, PA, USAJ. Madruga CRT-DST/AIDS SP, São Paulo, BrazilF. Urbina Hospital Nacional Edgardo Rebagliati Martins, Lima, PeruC. Katlama AP-HP, Hôpital Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, INSERM-Sorbonne Universités, Paris, FranceS. Schrader Schrader Clinic, Houston, TX, USAJ. Eron University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USAS. Chabria ViiV Healthcare, Branford, CT, USAA. Clark ViiV Healthcare, Brentford, UKA. Pierce ViiV Healthcare, Durham, NC, USAM. Lataillade ViiV Healthcare, Branford, CT, USAP. Ackerman ViiV Healthcare, Branford, CT, USAM. Mika
Speaker
ViiV Healthcare, Münchenbuchsee, Switzerland
|
|
P040
|
Professional practices and factors associated with antibiotic prescription for lower respiratory tract infections in nursing homes
Poster (only)
SSI
A. Roux
Speaker
Infectious Diseases Service, Lausanne University HospitalD. Vu Communicable disease unit, Division of General cantonal physician, Geneva Directorate of Health; Pediatric Infectious Diseases Unit, Department of Woman, Child and Adolescent, University Hospitals of GenevaA. Niquille Center for Primary Care and Public Health (Unisanté), Pharmacy, University of LausanneE. Rubli Geriatric Medicine and Geriatric Rehabilitation Division, Lausanne University Hospital T. Bizzozzero Department of Internal Medicine and Geriatrics, Morges HospitalA. Tahar Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University HospitalsT. Morlan Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University HospitalsD. Akpokavie Internal Medicine department, Trois Chênes HospitalM. Gandin Faculty of Medicine, University of GenevaA. Merkly Faculty of Medicine, University of GenevaA. Cassini Cantonal Doctor Office, Public Health Department, Canton of Vaud; Infection Prevention and Control Unit, Infectious Diseases Service, Lausanne University HospitalE. Glampedakis Cantonal Doctor Office, Public Health Department, Canton of Vaud; Infection Prevention and Control Unit, Infectious Diseases Service, Lausanne University HospitalN. Boillat-Blanco Infectious Diseases Service, Lausanne University Hospital
|
|
P041
|
|
|
P042
|
Effect of photodynamic therapy on skin microbiome (PHOMIC-III)
Poster (only)
SSI
T. Schweizer
Speaker
Department of Dermatology, University Hospital Zurich, University of ZurichJ. Würmli Department of Dermatology, University Hospital Zurich, University of ZurichH. Koliwer-Brandl Institute of Medical Microbiology, University of ZurichA. Egli Institute of Medical Microbiology, University of ZurichL. Imhof Department of Dermatology, University Hospital Zurich, University of ZurichP. Bosshard Department of Dermatology, University Hospital Zurich, University of ZurichY. Achermann Department of Dermatology, University Hospital Zurich, University of Zurich and Department of Internal Medicine, Hospital Zollikerberg
|
|
P043
|
|
|
P044
|
Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19
Poster (only)
SSI
M. Van Singer
Speaker
Infectious Diseases Service of Lausanne University Hospital (CHUV)T. Brahier Infectious Diseases Service of Lausanne University Hospital (CHUV)J. Koch Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St.Gallen, St.GallenO. Hugli Emergency Department, University Hospital of Lausanne, SwitzerlandA. Weckman Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaK. Zhong Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaT. Kain Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaA. Leligdowicz Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaE. Bernasconi Division of infectious diseases, Ente Ospedaliero Cantonale, Lugano, University of Geneva and University of Southern Switzerland, Lugano, SwitzerlandA. Ceschi Division of infectious diseases, Ente Ospedaliero Cantonale, Lugano, University of Geneva and University of Southern Switzerland, Lugano, SwitzerlandK. Kain Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaW. Albrich Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St.Gallen, St.GallenN. Boillat-Blanco Infectious Diseases Service of Lausanne University Hospital (CHUV)
|
|
P045
|
|
|
P046
|
|
|
P047
|
|
|
P048
|
|
|
P049
|
|
|
P050
|
Impact of Multidisciplinary Endocarditis Team on management of infective endocarditis
Poster (only)
SSI
V. Zimmermann
Speaker
Lausanne University Hospital and University of LausanneN. Fourré Lausanne University Hospital and University of LausanneB. Guery Lausanne University Hospital and University of LausanneP. Tozzi Lausanne University Hospital and University of LausanneM. Kirsch Lausanne University Hospital and University of LausanneP. Monney Lausanne University Hospital and University of LausanneM. Papadimitriou-Olivgeris Lausanne University Hospital and University of Lausanne
|
|
P051
|
Lenacapavir with bNAbs GS-5423 and GS-2872 dosed every 6 months in people with HIV
Poster (only)
SSI
J. Eron University of North CarolinaS. Little University of CaliforniaG. Crofoot CrofootMD Clinic and Research CenterP. Cook East Carolina UniversityP. Ruane Ruane Clinical Research GroupD. Jayaweera University of Miami, Miller School of MedicineE. DeJesus Orlando Immunology CenterS. Waldman University of California, DavisM. Mehrotra Gilead Sciences, Inc.L. VanderVeen Gilead Sciences, Inc.H. Huang Gilead Sciences, Inc.S. Collins Gilead Sciences, Inc.T. Grabinger
Speaker
Gilead SciencesJ. Baeten Gilead Sciences, Inc.M. Caskey Rockefeller University
|
|
P052
|
|
|
P053
|
|
|
P054
|
Superinfections in hospitalized COVID 19 patients (SUPER Covid-19): data from the multicentric retrospective CH-SUR cohort study of hospitalized COVID-19 patients in Switzerland
Poster (only)
SSI
G. Scanferla
Speaker
Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, SwitzerlandA. Blöchlinger Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, SwitzerlandV. Bättig Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, SwitzerlandM. Büttcher Cantonal Hospital of Lucerne, Children’s Hospital, Pediatric Infectious Diseases, Lucerne, SwitzerlandA. Cusini Department of General Medicine, Cantonal Hospital of Grisons, Chur, SwitzerlandA. Iten Service of Prevention and Infection Control, Directorate of Medicine and Quality, University Hospital Geneva, Geneva, SwitzerlandO. Keiser Institute of Global Health, CAMPUS BIOTECH, Geneva, SwitzerlandR. Sommerstein Faculty of Health Sciences and Medicine, Clinic St. Anna, University of Lucerne, Lucerne, SwitzerlandJ. Sobel Institute of Global Health, CAMPUS BIOTECH, Geneva, SwitzerlandW. Albrich Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland
|
|
P055
|
Clinical relevance of HIV low-level viremia in the dolutegravir era: data from the Viral Load Cohort North-East Lesotho (VICONEL)
Poster (only)
SSI
M. Kohler
Speaker
University and University Hospital Basel, Basel, SwitzerlandJ. Brown University and University Hospital Basel, Basel, SwitzerlandN. Tschumi University and University Hospital Basel, Basel, SwitzerlandM. Lerotholi University and University Hospital Basel, Basel, SwitzerlandL. Motaboli SolidarmedM. Mokete SolidarmedF. Chammartin University and University Hospital Basel, Basel, SwitzerlandN. Labhardt University and University Hospital Basel, Basel, Switzerland
|
|
P056
|
|
|
P057
|
|
|
P058
|
|
|
P059
|
Comparison of Telomere Length Changes Over 48 Weeks in SALSA Study: DTG/3TC vs CAR
Poster (only)
SSI
M. Underwood ViiV Healthcare, Durham, NCJ. Oyee GSK, Brentford, UKJ. Horton Parexel International, Durham, NC, USAT. Chakraborty GSK, Bangalore, IndiaC. Parry ViiV Healthcare, Brentford, UKR. Wang ViiV Healthcare, Durham, NCJ. Lin University of California, San Francisco, CA, USAM. Sithamparanathan ViiV Healthcare, Brentford, UKB. Jones ViiV Healthcare, Brentford, UKB. Wynne ViiV Healthcare, Durham, NC, USAC. Man ViiV Healthcare, Durham, NC, USAA. Zolopa ViiV Healthcare, Durham, NC, USAT. Edinger
Speaker
ViiV Healthcare
|
|
P060
|
Results at 12 months post-vaccination with a respiratory syncytial virus (RSV) prefusion F protein investigational vaccine (RSVPREF3 OA)
Poster (only)
SSI
P. Runge
Speaker
GSK Pharma SchweizT. Schwarz Klinikum Würzburg Mitte, Campus Juliusspital, Würzburg, GermanyS. Hwang En Chu Kong Hospital, New Taipei City, Taipei Veterans General Hospital, and National Yang Ming Chiao Tung University School of Medicine, Taipei, TaiwanP. Ylisastigui Alliance For MultiSpecialty Research, Fort Myers, United StatesC. Liu China Medical University Hospital, Taichung, TaiwanK. Takazawa Medical Corporation Shinanokai, Shinanozaka Clinic, Tokyo, JapanM. Yono Nishi-Kumamoto Hospital, Kumamoto, JapanJ. Ervin The Alliance for Multispecialty Research, Kansas City, United StatesC. Andrews IMA Research San Antonio, Texas, United StatesC. Fogarty Spartanburg Medical Research, South Carolina, United StatesT. Eckermann Praxis Dr. med. Irmgard Maier-Bosse, Munich, GermanyD. Collete GSK, Rixensart, BelgiumM. de Heusch GSK, Wavre, BelgiumN. De Schrevel GSK, Rixensart, BelgiumB. Salaun GSK, Rixensart, BelgiumA. Lambert GSK, Wavre, BelgiumC. Maréchal GSK, Wavre, BelgiumP. Nakanwagi GSK, Wavre, BelgiumM. Lievens GSK, Wavre, BelgiumV. Hulstrøm GSK, Wavre, Belgium
|
|
P061
|
Durable Efficacy of Switching From a 3-/4-Drug Tenofovir Alafenamide (TAF)-Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine (DTG/3TC) in the TANGO Study Through Week 196
Poster (only)
SSI
S. De Wit CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, BelgiumF. Bonnet CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, FranceO. Osiyemi Triple O Research Institute PA, West Palm Beach, FL, USAF. Bisshop Holdsworth House Medical Brisbane, Queensland, AustraliaJ. Olalla Unidad de Medicina Interna, Hospital Costa del Sol, Marbella, SpainJ. Routy McGill University Health Centre, Montreal, QC, CanadaC. Wyen Praxis am Ebertplatz, Cologne, GermanyR. Moodley ViiV Healthcare, Brentford, UKK. Pappa ViiV Healthcare, Durham, NC, USAR. Wang ViiV Healthcare, Durham, NC, USAJ. Oyee GSK, Brentford, UKP. Saggu GSK, Brentford, UKE. Letang ViiV Healthcare, Madrid, SpainB. Wynne ViiV Healthcare, Durham, NC, USAB. Jones ViiV Healthcare, Brentford, UKK. Smith ViiV Healthcare, Durham, NC, USAM. Ait-Khaled ViiV Healthcare, Brentford, UKM. Mika
Speaker
ViiV Healthcare, Münchenbuchsee, Switzerland
|
|
P062
|
|
|
P063
|
Performance of serological scores to detect liver steatosis among people with HIV
Poster (only)
SSI
C. Riebensahm
Speaker
Inselspital, Bern University Hospital, University of Bern, SwitzerlandJ. Brocker Inselspital, Bern University Hospital, University of Bern, SwitzerlandA. Berzigotti Inselspital, Bern University Hospital, University of Bern, SwitzerlandH. Günthard University Hospital Zurich, University of Zurich P. Tarr Kantonsspital Bruderholz, University of Basel H. Furrer Inselspital, Bern University Hospital, University of Bern, SwitzerlandA. Rauch Inselspital, Bern University Hospital, University of Bern, SwitzerlandG. Wandeler Inselspital, Bern University Hospital, University of Bern, SwitzerlandB. Surial Inselspital, Bern University Hospital, University of Bern, Switzerland
|
|
P064
|
Performance of vital signs, clinical prediction rule and biomarkers as predictors of radiological pneumonia and hospital admission in primary care versus emergency department settings
Poster (only)
SSI
A. Roux
Speaker
Infectious Diseases Service, Lausanne University HospitalT. Brahier Infectious Diseases Service, Lausanne University HospitalJ. Knüsli Infectious Diseases Service, Lausanne University HospitalL. Lhopitallier Gare 10 Lausanne General PracticeC. Fischer Faculty of Medicine, University of Lausanne Y. Mueller Department of Family Medicine, Centre for Primary Care and Public Health (Unisanté), University of LausanneN. Senn Department of Family Medicine, Centre for Primary Care and Public Health (Unisanté), University of LausanneA. Kronenberg Institute for Infectious Diseases, University of BernD. Rotzinger Department of Diagnostic and Interventional Radiology, Lausanne University Hospital E. Tenisch Department of Diagnostic and Interventional Radiology, Lausanne University Hospital O. Hugli Emergency Department, Lausanne University Hospital K. Kain Tropical Disease Unit, Department of Medicine, University of TorontoN. Boillat-Blanco Infectious Diseases Service, Lausanne University Hospital
|
|
P065
|
Late re-engagement into HIV care among adults in the Swiss HIV Cohort Study
Poster (only)
SSI
A. Haas
Speaker
University of Bern, Bern, SwitzerlandK. Kusejko University of Zurich, Zurich, SwitzerlandM. Cavassini University Hospital of Lausanne, University of Lausanne, Lausanne, SwitzerlandH. Günthard University Hospital Zurich, University of Zurich, Zurich, SwitzerlandM. Stöckle University Hospital Basel, University of Basel, Basel, SwitzerlandA. Calmy Geneva University Hospital, University of Geneva, Geneva, SwitzerlandE. Bernasconi Regional Hospital of Lugano, Lugano, SwitzerlandP. Schmid Cantonal Hospital of St Gallen, St Gallen, SwitzerlandA. Rauch Bern University Hospital, University of Bern, Bern, SwitzerlandM. Egger University of Bern, Bern, SwitzerlandG. Wandeler Bern University Hospital, University of Bern, Bern, Switzerland
|
|
P066
|
Macrophages show unprecedented anti-HIV activity in HIV-infected iHMD-NSG mice
Poster (only)
SSI
L. Baroncini
Speaker
University Hospital ZurichC. Müller University Hospital ZurichN. Kadzioch University Hospital ZurichR. Wolfensberger University Hospital ZurichT. Mlambo University Hospital ZurichS. Bredl University Hospital ZurichS. Bredl University Hospital ZurichR. Speck University Hospital Zurich
|
|
P067
|
Group A Streptococcus antibiotic tolerance in necrotizing fasciitis
Poster (only)
SSI
N. Keller University Hospital ZurichM. Boumasmoud University Hospital ZurichF. Andreoni
Speaker
University Hospital ZurichA. Tarnutzer University Hospital ZurichM. von Matt University Hospital ZurichT. Scheier University Hospital ZurichJ. Epprecht University Hospital ZurichA. Gomez-Mejia University Hospital ZurichM. Huemer University Hospital ZurichE. Marques-Maggio University Hospital ZurichR. Schuepbach University Hospital ZurichS. Mairpady-Shambat University Hospital ZurichS. Brugger University Hospital ZurichA. Zinkernagel University Hospital Zurich
|
|
P068
|
|
|
P069
|
An unexpected culprit of cervical Spondylitis
Poster (only)
SSI
C. Gutmann
Speaker
Division of Infectious DiseasesA. Meyer Division of Internal MedicineA. Andrees Division of Internal MedicineV. Bansal Division of Infectious DiseasesU. Karrer Division of Infectious Diseases
|
|
P070
|
To die with or to die for COVID-19 infection: what 2022 has taught us
Poster (only)
SSI
M. Bongiovanni
Speaker
Ente Ospedaliero CantonaleS. Simon Ente Ospedaliero CantonaleB. Barda Ente Ospedaliero CantonaleG. Martinetti Lucchini Ente Ospedaliero CantonaleC. Di Benedetto Ente Ospedaliero CantonaleG. Merlani Cantonal Service for Public Health, Bellinzona, SwitzerlandE. Bernasconi Ente Ospedaliero Cantonale
|
|
P071
|
Performance of an HAV IgG rapid test from capillary whole-blood in Swiss opioid agonist therapy (OAT) patients
Poster (only)
SSI
A. Bregenzer
Speaker
Department of Infectious Diseases and Infection Prevention, Cantonal Hospital AarauS. Eichhorn Department of Infectious Diseases and Infection Prevention, Cantonal Hospital AarauP. Rippstein Outpatient Centre of Substitution Therapy HAG, Department of Addictive Disorders, Psychiatric Services Aargau, BruggM. Oberle Institute for Laboratory Medicine, Cantonal Hospital AarauC. Fux Department of Infectious Diseases and Infection Prevention, Cantonal Hospital Aarau
|
|
P072
|
B-free trial: Booster-free antiretroviral therapy for persons living with HIV and multidrug resistance
Poster (only)
SSI
M. Ballif
Speaker
Universitätsklinik für Infektiologie, Inselspital, BernA. Limacher Clinical Trial Unit, University of BernM. Correia da Silva Saúde Universitätsklinik für Infektiologie, Inselspital, BernD. Braun USZ UniversitätsSpital ZürichA. Calmy HUG Hôpitaux Universitaires de GenèveR. Kouyos USZ UniversitätsSpital ZürichE. Bernasconi Ospedale Regionale di LuganoM. Cavassini CHUV Centre Hospitalier Universitaire VaudoisM. Stoeckle Universitätsspital BaselP. Schmid Kantonsspital St. Gallen KSSGD. Haerry Positivrat Schweiz, Le Conseil Positif Suisse, ZürichH. Günthard USZ UniversitätsSpital ZürichA. Rauch Universitätsklinik für Infektiologie, Inselspital, BernB. Surial Universitätsklinik für Infektiologie, Inselspital, BernG. Wandeler Universitätsklinik für Infektiologie, Inselspital, Bern
|
|
P073
|
|
|
P074
|
|
|
P075
|
Absence of proviral HIV-1 evolution in early treated individuals with HIV-1 switching to dolutegravir monotherapy during 48 weeks
Poster (only)
SSI
L. Jörimann
Speaker
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandJ. Tschum Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandM. Zeeb Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandC. Leemann Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandC. Schenkel Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandK. Neumann Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandS. Chaudron Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandM. Zaheri Institute of Medical Virology (IMV), University of Zurich (UZH)P. Frischknecht Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandN. Neuner-Jehle Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandH. Kuster Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandD. Braun Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandC. Grube Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandR. Kouyos Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandK. Metzner Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandH. Günthard Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
|
|
P076
|
Efficacy and safety at 96 weeks of bulevirtide 2 mg or 10 mg monotherapy for chronic hepatitis D: results from an interim analysis of a phase 3 randomized study
Poster (only)
SSI
H. Wedemeyer Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule HannoverS. Aleman Karolinska University Hospital/Karolinska InstitutetM. Brunetto Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa; Department of Clinical and Experimental Medicine, University of PisaA. Blank Heidelberg University HospitalP. Andreone University of Modena and Reggio Emilia, Internal Medicine, Baggiovara HospitalP. Bogomolov State Budgetary Institution of Health Care of Moscow Region “Moscow Regional Research Clinical Institute After M.F. Vladimirsky”V. Chulanov FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation; Sechenov UniversityN. Mamonova FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian FederationN. Geyvandova Stavropol Regional HospitalV. Morozov LLC Medical Company “Hepatolog"O. Sagalova Southern Ural State Medical UniversityT. Stepanova Clinic of Modern MedicineC. Oberle
Speaker
Gilead Sciences, Inc.D. Manuilov Gilead Sciences, Inc.R. Mercier Gilead Sciences, Inc.Q. An Gilead Sciences, Inc.J. Flaherty Gilead Sciences, Inc.A. Osinusi Gilead Sciences, Inc.A. Lau Gilead Sciences, Inc.J. Schulze zur Wiesch Universitätsklinikum Hamburg-Eppendorf Medizinische Klinik Studienambulanz HepatologieM. Cornberg Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule HannoverS. Zeuzem University Hospital Frankfurt, Department of MedicineP. Lampertico Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology; CRC “A. M. and A. Migliavacca” Center for Liver Disease, University of Milan, Department of Pathophysiology and Transplantation
|
|
P078
|
No safety concerns observed when the adjuvanted recombinant zoster vaccine (RZV) and the COVID-19 mRNA-1273 booster were co-administered in ≥50-year-olds
Poster (only)
SSI
A. Naficy GSK, Rockville, MD, United StatesP. Pirrotta GSK, Wavre, BelgiumJ. Miller Clinical Development, Moderna, Inc., Cambridge, MA, United StatesB. Leav Clinical Development, Moderna, Inc., Cambridge, MA, United StatesA. Mwakingwe-Omari GSK, Rockville, MD, United StatesP. Runge
Speaker
GSK Pharma Schweiz
|
|
P079
|
|
|
P080
|
|
|
P081
|
Predicting Dolutegravir resistance in Southern Africa: the DTG MARISA model
Poster (only)
SSI
T. Loosli
Speaker
Universitätsspital Zurich, University of ZurichA. Hauser Universitätsspital Zurich, University of ZurichJ. Josi Universitätsspital Zurich, University of ZurichN. Han Universitätsspital Zurich, University of ZurichR. Lessells University of KwaZulu-NatalH. Günthard Universitätsspital Zurich, University of ZurichM. Egger University of BernR. Kouyos
Speaker
Universitätsspital Zurich, University of Zurich
|
|
P082
|
HEV seroprevalence and infection incidence in a contemporary Swiss cohort of HCT recipients
Poster (only)
SSI
J. Courjon
Speaker
HUG Hôpitaux Universitaires de GenèveV. Portillo HUG Hôpitaux Universitaires de GenèveS. Masouridi HUG Hôpitaux Universitaires de GenèveY. CHALANDON HUG Hôpitaux Universitaires de GenèveM. MAPPOURA HUG Hôpitaux Universitaires de GenèveS. MORIN HUG Hôpitaux Universitaires de GenèveF. GIANNOTTI HUG Hôpitaux Universitaires de GenèveA. MAMEZ HUG Hôpitaux Universitaires de GenèveS. YERLY FERRILLO HUG Hôpitaux Universitaires de GenèveM. Schibler HUG Hôpitaux Universitaires de GenèveC. van Delden HUG Hôpitaux Universitaires de GenèveD. Neofytos HUG Hôpitaux Universitaires de Genève
|
|
P083
|
|
|
P084
|
|
|
P085
|
Extraneurological Manifestations of Tick-borne Encephalitis Virus: Report of a Rare Case of TBE-associated Myocarditis and Review of the Literature
Poster (only)
SSI
M. Seneghini
Speaker
Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandF. Lugano Division of Internal Medicine, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandM. Maeder Division of Cardiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandR. Garcia-Boy Division of Human Immunology, Center for Laboratory Medicine, St. Gallen, SwitzerlandC. Strahm Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland
|
|
P086
|
Severe community-acquired pneumococcal ventriculitis as a complication of otogenic pneumococcal meningitis - a case report
Poster (only)
SSI
M. Seneghini
Speaker
Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandJ. Deppe Division of Neurology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandP. Balcerak Division of Neurology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandG. Kägi Division of Neurology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandW. Albrich Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland
|
|
P087
|
|
|
P088
|
|
|
P089
|
SOLAR 12-month results – randomized switch trial of CAB+RPV LA vs oral B/FTC/TAF
Poster (only)
SSI
M. Ramgopal Midway Immunology and Research Center, Fort Pierce, FL, USAA. Castagna Vita-Salute University San Raffaele Scientific Institute, Milan, ItalyC. Cazanave University Hospital of Bordeaux, Bordeaux, FranceV. Diaz-Brito Parc Sanitari Sant Joan de Deu, Sant Boi de Llobregat, SpainR. Dretler Infectious Disease Specialists of Atlanta, Decatur, GA, USA; S. Oka National Center for Global Health and Medicine, Tokyo, JapanO. Osiyemi Triple O Research Institute PA, West Palm Beach, FL, USAK. Sutton ViiV Healthcare, Durham, NC, USAD. Sutherland-Phillips ViiV Healthcare, Durham, NCA. Berni GSKC. Latham ViiV Healthcare, Durham, NCF. Zhang GSK, Collegeville, PA, USAR. D’Amico ViiV Healthcare, Durham, NC, USAJ. van Wyk ViiV Healthcare, Brentford, UKP. Rhein
Speaker
ViiV Healthcare, Münchenbuchsee, Switzerland
|
|
P090
|
|
|
P091
|
|
|
P092
|
|
|
P093
|
Three-year B/F/TAF use in treatment-naïve (TN) and treatment-experienced (TE) PLWH in the BICSTaR study in Canada, France and Germany
Poster (only)
SSI
S. Schellberg Novopraxis Berlin GbRP. Khaykin MainFachArztC. Wyen Praxis am EbertplatzJ. De Vet Spectrum HealthA. Wong Department of Medicine, University of SaskatchewanC. Duvivier Maladies Infectieuses Tropicales, Hop Necker Enfants MaladesO. Robineau University of Lille, Infectious Disease DepartmentB. Albuquerque Gilead Sciences GmbHS. Schreiber Gilead Sciences GmbHD. Thorpe Gilead Sciences Europe LtdM. Heinzkill Gilead Sciences GmbHS. Sahali Gilead Sciences, Inc.T. Saifi Gilead Sciences Canada, Inc.C. Oberle
Speaker
Gilead Sciences Switzerland SàrlT. Cassidy Gilead Sciences Europe LtdC. Spinner University Hospital Rechts der Isar, Department of Medicine II
|
|
P094
|
|
|
P095
|
|
|
P096
|
|
|
P097
|
|
|
P098
|
|
|
P099
|
Effectiveness of annual cantonal influenza campaign and vaccination in reducing influenza burden in nursing homes of Vaud
Poster (only)
SSHH
P. Cuiña-Iglesias Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)L. Qalla-Widmer Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)C. Riccio Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)B. Sobgoui Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)F. Battistella Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)A. Cassini Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)M. Nahimana Tessemo Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)E. Glampedakis
Speaker
Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)
|
|
P100
|
Current state of infection prevention and control in long-term-care facilities in Eastern Switzerland: first results within the OSKAR (Ostschweizer Kompetenznetz für Infektionsprävention in Alters-und Pflegeheimen)-Project
Poster (only)
SSHH
N. Bloch
Speaker
Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandF. Grässli Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandP. Kohler Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandJ. Kuhn Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandS. Kuster Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandM. Schlegel Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandD. Flury Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland
|
|
P101
|
|
|
P102
|
|
|
P103
|
|
|
P104
|
|
|
P105
|
|